Failure of cabergoline to prevent severe ovarian hyperstimulation syndrome in patients with extremely high estradiol levels.
Hwang
Jiann-Loung
JL
Department of Obstetrics and Gynecology, Shin Kong Wu Ho-Su Memorial Hospital, Taipei Medical University, Taipei, Taiwan.
Lin
Yu-Hung
YH
Seow
Kok-Min
KM
D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000077465:Cabergoline; D004873:Ergolines / Q000627:therapeutic use*; D004958:Estradiol / Q000097:blood*; D005260:Female; D006801:Humans; D016471:Ovarian Hyperstimulation Syndrome / Q000097:blood / Q000209:etiology / Q000517:prevention & control*; D010062:Ovulation Induction / Q000009:adverse effects*; D017211:Treatment Failure
D000970:Antineoplastic Agents; D004873:Ergolines; D004958:Estradiol; D000077465:Cabergoline